ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

PCI Files Application For Research Base COP

September 9, 1994

Gene Therapy Shows Positive Results In Phase III Trial

July 25, 2008

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986

In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work

June 20, 1986

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995